LGR5 CAR-T cells: A novel potential treatment against high grade serous ovarian cancer.

被引：0
|
作者：
Wang, Wanqi [1 ]
Bandara, Veronika [1 ]
Lokman, Noor [1 ]
Napoli, Silvana [1 ]
Gundsambuu, Batjargal [1 ]
Oehler, Martin [2 ]
Barry, Simon C. [1 ]
Ricciardelli, Carmela [1 ]
机构：
[1] Univ Adelaide, Adelaide, SA, Australia
[2] Royal Adelaide Hosp, Adelaide, SA, Australia
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5183
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer
    Newtson, Andreea
    Reyes, Henry
    Devor, Eric J.
    Goodheart, Michael J.
    Bosquet, Jesus Gonzalez
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [42] Pre-existing, poly-resistant cancer stem cells in high-grade serous ovarian cancer.
    Xie, Jingzhong
    Yamamoto, Yusuke
    Liew, Audrey-Ann
    Wang, Bailiang
    Mahalingam, Rajasekaran
    Duleba, Marcin
    Rao, Wei
    Niroula, Suchan
    Goller, Kristina
    Zhang, Yanting
    Wang, Shan
    Jazaeri, Amir
    Davies, Peter
    Torti, Suzy
    Draetta, Giulio
    Anderson, Matthew
    Brewer, Molly
    Crum, Christopher
    McKeon, Frank
    Xian, Wa
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 78 - 78
  • [43] Singling out tumor heterogeneity and chemoresistance in high-grade serous ovarian cancer.
    Erkan, Erdogan Pekcan
    Dai, Jun
    Zhang, Kaiyang
    Kaipio, Katja
    Lamminen, Tarja
    Mansuri, Naziha
    Suominen, Lasse
    Alkodsi, Amjad
    Huhtinen, Kaisa
    Hietanen, Sakari
    Hynninen, Johanna
    Grenman, Seija
    Carpen, Olli
    Hautaniemi, Sampsa
    Vaharautio, Anna
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 59 - 59
  • [44] Phenotypic and genomic characterization of intratumoral heterogeneity in high-grade serous ovarian cancer.
    Cunnea, Paula
    Curry, Ed
    Nixon, Katherine
    Wulandari, Ratri
    Thol, Kerstin
    Kwok, Chun Hei
    Ploski, Jennifer
    McNeish, Iain
    Christie, Elizabeth
    Bowtell, David
    Fotopoulou, Christina
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 42 - 42
  • [45] PAX8-directed nanotherapeutics for high-grade serous ovarian cancer.
    Chandrasekaran, Akshaya
    Ahmed, Mariam
    Holub, Nicole
    Wang, Wade
    Hammond, Paula T.
    Elias, Kevin M.
    CANCER RESEARCH, 2021, 81 (13)
  • [46] Drug resistance in end-stage high-grade serous ovarian cancer.
    Christie, Elizabeth L.
    Alsop, Kathryn
    Au-Yeung, George
    Pandey, Ahwan
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 17 - 17
  • [47] CAR-T cell therapy for the treatment of adult high-grade gliomas
    Park, Sangwoo
    Maus, Marcela V.
    Choi, Bryan D.
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [48] CAR-T cell therapy: a potential new strategy against prostate cancer
    Schepisi, Giuseppe
    Cursano, Maria Concetta
    Casadei, Chiara
    Menna, Cecilia
    Altavilla, Amelia
    Lolli, Cristian
    Cerchione, Claudio
    Paganelli, Giovanni
    Santini, Daniele
    Tonini, Giuseppe
    Martinelli, Giovanni
    De Giorgi, Ugo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
  • [49] The metastatic potential of high-grade serous ovarian cancer cells along disease progression.
    Ritch, Sabrina J.
    Goyeneche, Alicia A.
    Noman, Abu S.
    Telleria, Carlos M.
    CANCER RESEARCH, 2021, 81 (13)
  • [50] Cyclin E as a potential therapeutic target in high grade serous ovarian cancer
    Kanska, J.
    Zakhour, M.
    Taylor-Harding, B.
    Karlan, B. Y.
    Wiedemeyer, W. R.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 152 - 158
12345